Authors
Latest:
Targeting DLL3 in Small Cell Lung Cancer and Other Neuroendocrine CarcinomasDLL3 is an emerging therapeutic target in small cell lung cancer and other neuroendocrine carcinomas, with 1 FDA-approved therapy and several others under investigation.
Latest:
A Pharmacist’s Guide to the Management of Polycystic Ovarian SyndromePharmacists play an important role in managing patients with this complex condition.
Latest:
How Pharmacists Can Help Patients With Bipolar Disorder Make Informed Treatment DecisionsStudies suggest bipolar disorder is associated with increased potential for stroke and higher odds of experiencing poor outcomes.
Latest:
Valerian: Root of All Zzz’s or Just Another Bedtime Story?Several studies on valerian have been conducted in the past 50 years for indications varying from insomnia, anxiety, restless leg syndrome, headaches, and more.
Latest:
Evolving Standards of Care in the Systemic Treatment of Metastatic Urothelial CancerTreatment of advanced/metastatic urothelial cancer has changed dramatically in recent years. This review discusses the use, risks, and benefits of several novel therapies for this indication.
Latest:
Impact of a Community-Based Specialty Pharmacist in Identifying Drug Therapy Problems for New Adult Oncology PatientsThis abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Latest:
Social Determinants of Health Matter When Treating Patients With Breast CancerPharmacists play a critical role in treating patients with breast cancer and can help address their social determinant of health challenges.
Latest:
Rising Use of Herbal Supplements Creates Awareness of Risks During the Perioperative PeriodPharmacists can get involved by counseling patients on when to halt use of supplements, as well as proper use and selection of products.
Latest:
Clinical Overview: Tildrakizumab-asmn (Ilumya) for Plaque PsoriasisTildrakizumab-asmn is a humanized IgG1/k monoclonal anti-IL-23 antibody indicated for the treatment of adults with moderate-to-severe plaque psoriasis.
Latest:
Clinical Overview: Lecanemab Offers Hope for Patients With Alzheimer DiseaseLecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody that targets amyloid plaques, which are thought to play a role in the development and progression of Alzheimer disease.
Latest:
Introducing Obecabtagene Autoleucel: A New Chapter in ALL TreatmentObecabtagene autoleucel improves CAR T-cell therapy for B-cell ALL.
Latest:
Transitions of Care in Patients With Recurrent C. Diff: An Opportunity for Collaboration Among Community, Health System PharmacistsApproximately 450,000 cases of Clostridioides difficile infection occur each year in the United States and approximately 25% of patients treated for an initial episode will experience recurrence.
Latest:
Deprescribing Helps Optimize Medication UseFrequent reassessments of therapy regimens address polypharmacy, particularly for older patients.
Latest:
Future Management Considerations of RSVPanelists discuss the evolving management of RSV, highlighting the importance of increasing awareness and education, anticipating advances in testing, data reporting, and treatment options like monoclonal antibodies and antivirals, and considering future vaccination strategies such as booster doses to enhance prevention and patient outcomes.
Latest:
Building Resilience: Opportunities for US Pharma to Strengthen Public Health in Africa Amid Changing Aid PoliciesAfrica’s rapidly growing population, expected to reach 2.5 billion by 2050, means an increasing demand for health care and medications.
Latest:
Addressing Ongoing Hospital Pharmacy Staffing ChallengesAt a time when pharmacist burnout and turnover is higher than ever before, talent retention is increasingly a strategic imperative for hospitals.
Latest:
Clinical Outcomes of Oral Anticancer Regimens in NSCLC Patients Managed in an Integrated Health-System Specialty Pharmacy ProgramPharmacist interactions provide significant benefits for patients with non-small cell lung cancer treated with oral oncolytics.
Latest:
Healing Trust in Medicine in a Fractured Post-Pandemic LandscapeThe pandemic’s aftermath left lasting tensions in health care.
Latest:
Pharmacy Technicians as Non-Pharmacist Preceptors for a Sterile Compounding RotationRecognizing pharmacy technicians as non-pharmacist preceptors can provide an opportunity for professional development while encouraging technicians to practice at the top of their education and training activities.
Latest:
Walgreens Doubles Down on Care Team IntegrationBut the role of the pharmacy chain in health systems, primary care, and specialty is uncertain.
Latest:
The Benefit of Integrating Residency Workshops Into Pharmacy School CurriculumIn light of the growing numbers of students opting for post-graduate trainings, colleges and schools of pharmacy may want to consider offering electives geared toward exposing students to post-graduate career possibilities and provide guidance toward success.
Latest:
ASCO 2025: Racial Disparities and Advanced Staging in Early-Onset Colorectal CancerA study of early-onset colorectal cancer found significant racial disparities, with younger patients more frequently diagnosed at advanced stages.
Latest:
Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing SarcomaThis retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.
Latest:
RFID is the Future of Hospital Efficiency: Here’s Why You Should Get InvolvedRadio frequency identification-enabled automation for inventory management has only achieved its massive adoption in the retail space over the past 2 decades.
Latest:
Management of Cytopenia Post CAR T-Cell TherapyThis review explores cytopenia after CAR T-cell therapy, including its risk stratification and management with growth factors, thrombopoietin-receptor agonists, and hematopoietic stem cell boosts.
Latest:
Potential Safety Concerns With EvinacumabThis case report depicts a probable infusion reaction in a 61-year-old woman prescribed evinacumab for the treatment of familial hypercholesterolemia.
Latest:
Discussing the Role of the Pharmacist in the Management of Biliary Tract CancerPanelists discuss how pharmacists play a crucial role in biliary tract cancer management by leveraging their detailed medication knowledge to assist with treatment selection, develop comprehensive monitoring plans (especially for hyperphosphatemia with FGFR inhibitors and cardiac monitoring with HER2 therapies), educate patients about unique toxicities and self-management strategies, create clinic workflow algorithms for toxicity management, and advocate for maximizing time on therapy as long as patients maintain response or stable disease given the limited treatment options available for this rare cancer type.
Latest:
Pharmacists Are Over-Looked Travel SpecialistsAs the summer months approach, pharmacists can offer many services to ensure patients remain safe and healthy during their travels.
